Show simple item record

dc.contributor.authorUgalde Arbizu, Maider
dc.contributor.authorAguilera-Correa, John Jairo ORCID
dc.contributor.authorSan Sebastián Larzabal, Eider ORCID
dc.contributor.authorPáez, Paulina L.
dc.contributor.authorNogales, Estela
dc.contributor.authorEsteban, Jaime ORCID
dc.contributor.authorGómez-Ruiz, Santiago ORCID
dc.date.accessioned2023-08-07T11:02:49Z
dc.date.available2023-08-07T11:02:49Z
dc.date.issued2023-07-05
dc.identifier.citationPharmaceuticals 16(7) : (2023) // Article ID 961es_ES
dc.identifier.issn1424-8247
dc.identifier.urihttp://hdl.handle.net/10810/62120
dc.description.abstractAntibiotic resistance is a global problem and bacterial biofilms contribute to its development. In this context, this study aimed to perform the synthesis and characterization of seven materials based on silica mesoporous nanoparticles functionalized with three types of fluoroquinolones, along with Cu2+ or Ag+ species to evaluate the antibacterial properties against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa, including clinical and multi-drug-resistant strains of S. aureus and P. aeruginosa. In addition, in order to obtain an effective material to promote wound healing, a well-known proliferative agent, phenytoin sodium, was adsorbed onto one of the silver-functionalized materials. Furthermore, biofilm studies and the generation of reactive oxygen species (ROS) were also carried out to determine the antibacterial potential of the synthesized materials. In this sense, the Cu2+ materials showed antibacterial activity against S. aureus and E. coli, potentially due to increased ROS generation (up to 3 times), whereas the Ag+ materials exhibited a broader spectrum of activity, even inhibiting clinical strains of MRSA and P. aeruginosa. In particular, the Ag+ material with phenytoin sodium showed the ability to reduce biofilm development by up to 55% and inhibit bacterial growth in a “wound-like medium” by up to 89.33%.es_ES
dc.description.sponsorshipWe gratefully acknowledge funding from the research project RTI2018-094322-B-I00 financed by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”, the Research Thematic Network RED2022-134091-T financed by MCIN/AEI/10.13039/501100011033, the University of the Basque Country UPV/EHU (GIC18/143) and (GIU20/028) and the Gobierno Vasco/Eusko Jaurlaritza (IT1755-22).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MICIU/RTI2018-094322-B-I00es_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/RED2022-134091-Tes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMSNes_ES
dc.subjectfluoroquinolonees_ES
dc.subjectcopperes_ES
dc.subjectsilver chloridees_ES
dc.subjectbiofilmes_ES
dc.titleAntibacterial Properties of Mesoporous Silica Nanoparticles Modified with Fluoroquinolones and Copper or Silver Specieses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2023-07-28T12:21:48Z
dc.rights.holder© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1424-8247/16/7/961es_ES
dc.identifier.doi10.3390/ph16070961
dc.departamentoesQuímica aplicada
dc.departamentoeuKimika aplikatua


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).